ArticleMedical oncology (Northwood, London, England)2014

Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.

Vladimir M Moiseyenko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.